2: Treating Hepatitis C in People with Substance Use Disorder
Details
Description
This virtual event is the second session in the upcoming series entitled "Intersecting Epidemics in the Context of Ending the Epidemic: Tackling HIV, Substance Use, and HCV". This series is co-sponsored by the MidAtlantic AIDS Education and Training Center (MAAETC), the National Alliance for HIV Education and Workforce Development (NAHEWD), the Opioid Response Network (ORN), the Mid-Atlantic Regional Public Health Training Center, and the Central East Addiction Technology Transfer Center (ATTC).
The audience for this program is mixed- HIV providers, substance use disorder treatment programs, opioid treatment programs and others.
Session objectives:
By the end of the presentation, participants will be able to:
1. Discuss the latest treatment considerations for hepatitis C
2. Describe best practices for hepatitis C treatment in people with HIV and/or Substance Use Disorder
Session Schedule:
- 8:45am-9:00am - Welcome, Logistics, Introductions and Overview
- 9:00am-12:20pm - Didactic presentations and panel discussions
Accreditation
To be eligible to receive any credit for attending this event, you must attend the event in its entirety and complete all required evaluations.
Continuing Nursing Education (CNE): The MidAtlantic AIDS Education and Training Center is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association Approver Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Social Work: This program is offered for 3.0 CE hours of social work continuing education through co-sponsorship of the University of Pittsburgh's School of Social Work, a Council on Social Work Education accredited school and therefore a PA pre-approved provider of social work continuing education. These credit hours satisfy requirements for LSW/LCSW, LMFT, and LPC biennial license renewal.
Continuing Medical Education (CME): This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Pittsburgh School of Medicine and MidAtlantic AIDS Education and Training Center. The University of Pittsburgh School of Medicine accredited by the ACCME to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this live activity for 3.0 AMA PRA Category 1 Credit™.
Addiction Treatment Professionals: Central East ATTC is a NAADAC approved continuing education provider and has approved up to 3.0 contact hours for this event.
Continuing Education credits issued for participation in CE activity may not apply toward license renewal in all states. It is the responsibility of each participant to verify the requirements of their state licensing board(s).
Faculty and Planning Committee Disclosures
James A. Ealy, MA. Ingrid Godfrey MPH Susan Thompson, BS and Kathleen Wolff, MSN, CRNP have no relationships to disclose
Joanne Gilmore, MSN, CRNP is on the HCV speaker’s bureaus of Gilead Sciences, Inc. and AbbVie. She will support her presentation and clinical recommendations with the "best available evidence" from the medical literature.
Materials
Topics
A variety of the listed topics will be discussed at this event.
- Harm Reduction/Safe Injection
- HIV Transmission Risk Assessment
- HIV diagnosis (i.e. HIV testing)
- Linkage to Care
- Hepatitis C
- Medication-assisted therapy for substance use disorders (i.e. buprenorphine, methadone, and/or naltrexone)
- Substance use disorders
- Opioid use disorder